Hollandbio welcomes QPS as a new member 

Hollandbio connects, represents and supports the Dutch biotech sector. We are very proud to represent more than 270 companies: from start-ups, small and medium-sized enterprises to large companies, active in health, nutrition or biobased economy. Today we welcome our newest member, QPS Holdings, LLC (QPS), a global, full-service Clinical Research Organization (CRO) with extensive facilities in Groningen. The company headquarters is in Newark, Delaware, USA, and it operates facilities across the USA, Europe, Taiwan, Australia, and India.   

QPS is an award-winning global CRO providing discovery, bioanalysis, preclinical and clinical drug development services since 1995. Its mission is to accelerate pharmaceutical breakthroughs across the globe by delivering custom-built research services in Toxicology, Pharmacology, DMPK, Bioanalysis, Translational Medicine, Clinical Trial Units and Clinical Research Services, about which QPS shared the following with us: 

• Toxicology: Over the past two decades, QPS has performed thousands of GLP studies for pharmaceutical and biotechnology companies, covering many different disease areas. This vast experience attests to our ability to effectively deliver high-quality toxicology data solutions at our preclinical site in Asia. 

• Pharmacology: QPS offers an array of predictive disease models, as well as unparalleled experience with validated in vitro and in vivo models covering the majority of pharmacological targets for nonalcoholic steatohepatitis (NASH), inflammatory bowel disease (IBD), psoriasis and wound healing.Drug Metabolism and Pharmacokinetics (DMPK): With immediate access to a team of senior scientists with decades of pharmaceutical and biotech experience, QPS guides you through the appropriate preclinical studies across a broad range of compound structures and therapeutic targets. 

• Bioanalysis: QPS is built on a worldwide network of resources in bioanalysis for small molecules and biologics, with state-of-the-art facilities in the USA, Europe and Asia. Find out how a strategic outsourcing alliance with QPS can provide you with world-class operational and service excellence. 

• Translational Medicine: QPS offers specialized biomarker assay capabilities that support the development of targeted therapies and personalized medicines. Our CLIA-certified and GLP-compliant laboratories are ready to fast-track your RT-qPCR/QPCR and serological assays and vaccine development programs.  

• Clinical Development: At QPS, we have built a world-class clinical operations services model. We offer industry-leading full-service Phase I–IV clinical trial capabilities, including multiple Phase I clinics, medical and regulatory affairs, project & data management, clinical pharmacology, trial monitoring, and more. 

For more information about the extensive range of services offered by QPS, please visit their website.